These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37208329)

  • 21. Unraveling the Immune Regulatory Functions of USP5: Implications for Disease Therapy.
    Gu J; Chen C; He P; Du Y; Zhu B
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The deubiquitinase Leon/USP5 interacts with Atg1/ULK1 and antagonizes autophagy.
    Pai YL; Lin YJ; Peng WH; Huang LT; Chou HY; Wang CH; Chien CT; Chen GC
    Cell Death Dis; 2023 Aug; 14(8):540. PubMed ID: 37607937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.
    Li J; Li H; Zhu W; Zhou B; Ying J; Wu J; Zhang H; Sun H; Gao S
    J Cell Mol Med; 2020 Jan; 24(2):1370-1382. PubMed ID: 31845546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
    Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
    J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling the Mechanism of Action of Ubiquitin-Specific Protease 5 and Its Inhibitors in Tumors.
    Wang J; Fang S; Jiang Y; Hua Q
    Clin Med Insights Oncol; 2024; 18():11795549241281932. PubMed ID: 39391229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
    Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kawasaki disease: ubiquitin-specific protease 5 promotes endothelial inflammation via TNFα-mediated signaling.
    Huang C; Wang W; Huang H; Jiang J; Ding Y; Li X; Ma J; Hou M; Pu X; Qian G; Lv H
    Pediatr Res; 2023 Jun; 93(7):1883-1890. PubMed ID: 36329225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy.
    Jiang Y; Hong K; Zhao Y; Xu K
    Front Immunol; 2023; 14():1228200. PubMed ID: 37415977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
    Chen XH; Xu YJ; Wang XG; Lin P; Cao BY; Zeng YY; Wang Q; Zhang ZB; Mao XL; Zhang T
    Acta Pharmacol Sin; 2019 Dec; 40(12):1568-1577. PubMed ID: 31197245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma.
    Meng J; Ai X; Lei Y; Zhong W; Qian B; Qiao K; Wang X; Zhou B; Wang H; Huai L; Zhang X; Han J; Xue Y; Liang Y; Zhou H; Chen S; Sun T; Yang C
    Theranostics; 2019; 9(2):573-587. PubMed ID: 30809294
    [No Abstract]   [Full Text] [Related]  

  • 31. USP5/Leon deubiquitinase confines postsynaptic growth by maintaining ubiquitin homeostasis through Ubiquilin.
    Wang CH; Huang YC; Chen PY; Cheng YJ; Kao HH; Pi H; Chien CT
    Elife; 2017 May; 6():. PubMed ID: 28489002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage-derived extracellular vesicles regulates USP5-mediated HDAC2/NRF2 axis to ameliorate inflammatory pain.
    Qu Y; Xu Y; Jiang Y; Yu D; Jiang X; Zhao L
    FASEB J; 2021 Sep; 35(9):e21332. PubMed ID: 34423867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity.
    Park SH; Lee J; Yun HJ; Kim SH; Lee JH
    Ann Lab Med; 2024 Sep; 44(5):426-436. PubMed ID: 38529546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain.
    Gadotti VM; Caballero AG; Berger ND; Gladding CM; Chen L; Pfeifer TA; Zamponi GW
    Mol Pain; 2015 Mar; 11():12. PubMed ID: 25889575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. USP5 negatively regulates the activation of NLRP3 inflammasomes and participates in the pathological and physiological processes of Sjogren's syndrome.
    He J; Chen Y; Xu M; Wu S
    Int Immunopharmacol; 2024 Jun; 135():112274. PubMed ID: 38772301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ubiquitin-specific protease 5 in the inflammatory response of chronic periodontitis.
    Chen Q; Su J; Chen X
    Oral Dis; 2023 Apr; 29(3):1234-1241. PubMed ID: 34953100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smurf1 represses TNF-α production through ubiquitination and destabilization of USP5.
    Qian G; Ren Y; Zuo Y; Yuan Y; Zhao P; Wang X; Cheng Q; Liu J; Zhang L; Guo T; Liu C; Zheng H
    Biochem Biophys Res Commun; 2016 Jun; 474(3):491-496. PubMed ID: 27133717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.
    Sun Z; Mai H; Xue C; Fan Z; Li J; Chen H; Huo N; Kang X; Tang C; Fang L; Zhao H; Han Y; Sun C; Peng H; Du Y; Yang J; Du N; Xu X
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
    Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
    Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
    Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
    Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.